IP Library Granted Patent US 8,598,353
Granted Patent B2
US 8,598,353 · App. 12/950,718 · Granted Dec 3, 2013

Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,598,353
App. No.
12/950,718
Granted
Dec 3, 2013
Kind
B2
Abstract

The present invention is directed to benzazole compounds that inhibit β-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment or prevention of diseases in which BACE is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which BACE is involved.

Claims (89)

1. A compound selected from the group consisting of:

2-(4-Chloro-benzoylamino)-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

Isoquinoline-3-carboxylic acid [7-(1H-benzoimidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [7-(benzothiazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [7-([1,3,4]thiadiazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [4-(pyridin-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [4-(pyridin-3-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

2-[(1H-Indole-2-carbonyl)-amino]-1H-benzoimidazole-4-carboxylic acid (1H-benzoimidazol-2-yl)-amide,

Isoquinoline-3-carboxylic acid [5-(1H-benzoimidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [4-(1H-indazol-5-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [4-(quinolin-3-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [5-(benzothiazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [5-(thiazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

2-Benzoylamino-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

Isoquinoline-3-carboxylic acid {4-[(furan-2-ylmethyl)-carbamoyl]-1H-benzoimidazol-2-yl}-amide,

Isoquinoline-3-carboxylic acid [4-(2-phenoxy-phenylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [4-(3-phenoxy-phenylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [4-(4-phenoxy-phenylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [4-(1S-phenyl-ethylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

2-[(Benzo[b]thiophene-2-carbonyl)-amino]-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-[(Naphthalene-2-carbonyl)-amino]-1H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-[(1H-Indole-2-carbonyl)-amino]-1H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-(3,5-Difluoro-benzoylamino)-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-(4-Fluoro-benzoylamino)-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

Isoquinoline-3-carboxylic acid [4-(2-thiophen-2-yl-ethylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid (7-phenylcarbamoyl-1H-benzoimidazol-2-yl)-amide,

Isoquinoline-3-carboxylic acid {4-[(5-methyl-furan-2-ylmethyl)-carbamoyl]-1H-benzoimidazol-2-yl}-amide,

Isoquinoline-3-carboxylic acid (7-benzylcarbamoyl-1H-benzoimidazol-2-yl)-amide,

Isoquinoline-3-carboxylic acid {4-[(thiophen-2-ylmethyl)-carbamoyl]-1H-benzoimidazol-2-yl}-amide,

Isoquinoline-3-carboxylic acid (7-phenethylcarbamoyl-1H-benzoimidazol-2-yl)-amide,

Isoquinoline-3-carboxylic acid (7-ethylcarbamoyl-1H-benzoimidazol-2-yl)-amide,

Isoquinoline-3-carboxylic acid (7-tert-butylcarbamoyl-1H-benzoimidazol-2-yl)-amide,

2-[(Benzofuran-2-carbonyl)-amino]-1H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

Isoquinoline-3-carboxylic acid {4-[(benzo[b]thiophen-2-ylmethyl)-carbamoyl]-1H-benzoimidazol-2-yl}-amide,

Isoquinoline-3-carboxylic acid {4-[(benzothiazol-2-ylmethyl)-carbamoyl]-1H-benzoimidazol-2-yl}-amide,

Isoquinoline-3-carboxylic acid {4-[(1-methyl-1H-benzoimidazol-2-ylmethyl)-carbamoyl]-1H-benzoimidazol-2-yl}-amide,

Isoquinoline-3-carboxylic acid {4-[2-(1H-benzoimidazol-2-yl)-ethylcarbamoyl]-1H-benzoimidazol-2-yl}-amide,

2-[2-(4-Fluoro-phenyl)-acetylamino]-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-(4-Fluoro-3-methoxy-benzoylamino)-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-(3,4-Dimethoxy-benzoylamino)-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

Isoquinoline-3-carboxylic acid {4-[(thiazol-2-ylmethyl)-carbamoyl]-1H-benzoimidazol-2-yl}-amide,

Isoquinoline-3-carboxylic acid {4-[(1H-benzoimidazol-2-ylmethyl)-carbamoyl]-1H-benzoimidazol-2-yl}-amide,

2-(4-Trifluoromethyl-benzoylamino)-1H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-(4-Phenoxy-benzoylamino)-1H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

Quinoline-3-carboxylic acid [7-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Quinoline-2-carboxylic acid [7-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

2-[(Furan-3-carbonyl)-amino]-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-(4-tert-Butyl-benzoylamino)-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-(4-Nitro-benzoylamino)-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-(4-Methoxy-benzoylamino)-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-[(1H-Imidazole-2-carbonyl)-amino]-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-(4-Isopropyl-benzoylamino)-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-(3-Fluoro-benzoylamino)-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-(2-Fluoro-benzoylamino)-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-[(5-Chloro-benzofuran-2-carbonyl)-amino]-1H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

6,7-Dimethoxy-isoquinoline-3-carboxylic acid [7-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

6,7-Dimethoxy-isoquinoline-3-carboxylic acid [7-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

2-(2-Chloro-benzoylamino)-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

1H-Indazole-3-carboxylic acid [7-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

2-[(1-Methyl-1H-indole-2-carbonyl)-amino]-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

1-Methyl-1H-indazole-3-carboxylic acid [7-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [4-(5-phenyl-1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

2-[(5-Methyl-1H-indole-2-carbonyl)-amino]-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-[(6-Phenoxy-pyridine-2-carbonyl)-amino]-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-[(1-Benzyl-1H-indole-2-carbonyl)-amino]-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-[(1-Propyl-1H-indole-2-carbonyl)-amino]-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

2-[(1,5-Dimethyl-1H-indole-2-carbonyl)-amino]-3H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

Isoquinoline-3-carboxylic acid [4-(1H-imidazol-2-ylcarbamoyl)-6-nitro-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [6-amino-4-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [4-(1H-imidazol-2-ylcarbamoyl)-6-isobutyrylamino-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [6-benzoylamino-4-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazo-1-2-yl]-amide,

Isoquinoline-3-carboxylic acid [4-(1H-imidazol-2-ylcarbamoyl)-6-(3-methyl-butyrylamino)-1H-benzoimidazol-2-yl]-amide,

Isoquinoline-3-carboxylic acid [7-(1H-imidazol-2-ylcarbamoyl)-5-phenylacetylamino-1H-benzoimidazo-1-2-yl]-amide,

2-[(5-Phenylethynyl-pyridine-3-carbonyl)-amino]-1H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide, and

2-[(6-Phenylethynyl-pyridine-2-carbonyl)-amino]-1H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide,

or a pharmaceutically acceptable salt thereof.

2. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier, excipient, or diluent.

3. 1-Methyl-1H-indazole-3-carboxylic acid [7-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide or a pharmaceutically acceptable salt thereof.

4. A pharmaceutical composition comprising the compound of claim 3 .

5. Isoquinoline-3-carboxylic acid [5-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide or a pharmaceutically acceptable salt thereof.

6. A pharmaceutical composition comprising the compound of claim 5 .

7. Isoquinoline-3-carboxylic acid [4-(4,5,6,7-tetrahydro-1H-benzoimidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide or a pharmaceutically acceptable salt thereof.

8. A pharmaceutical composition comprising the compound of claim 7 .

9. 1-Methyl-isoquinoline-3-carboxylic acid [4-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide or a pharmaceutically acceptable salt thereof.

10. A pharmaceutical composition comprising the compound of claim 9 .

11. Isoquinoline-1-carboxylic acid [4-(1H-imidazol-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide or a pharmaceutically acceptable salt thereof.

12. A pharmaceutical composition comprising the compound of claim 11 .

13. 2-[(6-Cyclopropylethynyl-pyridine-2-carbonyl)-amino]-1H-benzoimidazole-4-carboxylic acid (1H-imidazol-2-yl)-amide or a pharmaceutically acceptable salt thereof.

14. A pharmaceutical composition comprising the compound of claim 13 .

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA PREVIOUSLY RECORDED AT REEL: 036254 FRAME: 0792. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 24, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS II LLC
Reel/Frame 036675/0399 →
RELEASE OF SECURITY INTEREST Recorded Aug 3, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS I LLC
Reel/Frame 036254/0792 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2015
From: VTVX HOLDINGS II LLC
To: VTV THERAPEUTICS LLC
Reel/Frame 036242/0362 →
CHANGE OF NAME Recorded Jul 30, 2015
From: HIGH POINT PHARMACEUTICALS, LLC
To: VTVX HOLDINGS II LLC
Reel/Frame 036236/0159 →
SECURITY INTEREST Recorded Feb 26, 2015
From: HIGH POINT PHARMACEUTICALS, LLC
To: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
Reel/Frame 035103/0029 →
NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS FOR REEL/FRAME 030982/0793 Recorded Apr 7, 2014
From: M&F TTP HOLDINGS LLC
To: HIGH POINT PHARMACEUTICALS, LLC
Reel/Frame 032621/0867 →
SECURITY AGREEMENT Recorded Aug 9, 2013
From: HIGH POINT PHARMACEUTICALS, LLC
To: M&F TTP HOLDINGS LLC C/O MACANDREWS & FORBES HOLDINGS INC.
Reel/Frame 030982/0793 →